Clinical Trials
Closed
Phase
SWOG Clinical Trial Number
SWOG-8220
Evaluation of 2' Deoxycorformycin (DCF) in Advanced Mycosis Fungoides
Activated
08-11-1982
Closed
03-22-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8217
Evaluation of Spirogermanium (NSC-192965) in Adenocarcinoma of the Prostate
Activated
08-11-1982
Closed
03-22-1985
Closed
Phase
SWOG Clinical Trial Number
SWOG-8211
Evaluation of Cis-Diamminedichloroplatinum in Disseminated Gastric Adenocarcinoma
Activated
08-11-1982
Closed
10-03-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8269
Concurrent Chemo-Radiotherapy for Limited Small Cell Carcinoma of the Lung OPENED GROUPWIDE: 3/22/85
Activated
08-11-1982
Closed
03-20-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8218
Evaluation of Spirogermanium (NSC-192965) in Renal Cell Carcinoma
Activated
07-21-1982
Closed
10-18-1983
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8213
Evaluation of Aclacinomycin A in Refractory Multiple Myeloma TEMPORARILY CLOSED: 3/22/85
Activated
07-21-1982
Closed
09-27-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8207
AZQ in Advanced Renal Cell Carcinoma
Activated
07-09-1982
Closed
03-16-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8263
Combined Radiation Therapy and Chemotherapy as Adjuvant Treatment for DukesB2C Colon Cancer
Activated
07-09-1982
Closed
10-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8117
Evaluation of Bisantrene Hydrochloride in Refractory Ovarian Cancer
Activated
06-15-1982
Closed
12-05-1983
Closed
Phase
SWOG Clinical Trial Number
SWOG-8206
Evaluation of Aclacinomycin A in Colorectal Carcinoma
Activated
06-02-1982
Closed
08-25-1983
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8108
Evaluation of Bisantrene Hydrochloride in Refractory Multiple Myeloma
Activated
06-02-1982
Closed
03-16-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8107
Management of Disseminated Melanoma, Master Protocol
Activated
05-26-1982
Closed
11-15-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8260
Treatment of Non-Small Cell Bronchogenic Carcinoma (NSCBC) With Vinblastine and Mitomycin-C (VeMi)
Activated
05-26-1982
Closed
12-23-1982
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8124/25/26
Treatment of Acute Non-Lymphocytic Leukemia with Conventional Induction, Consolidation Chemotherapy: Maintenance with Chemotherapy Versus Bone Marrow Transplantation Following Total Body Irradiation
Research Committee(s)
Leukemia
Activated
05-11-1982
Closed
09-27-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8262
Evaluation of Aclacinomycin A in Adult Acute Leukemia
Activated
04-26-1982
Closed
12-05-1983
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8110
Treatment of Advanced Germ Cell Neoplasms of the Testis: A Comparison of Remission Induction with Vinblastine, Bleomycin and Cis-Platinum (VBP) vs. Vinblastine, Cis-Platinum and VP-16-213 (VPV); Surgical Maintenance Therapy and Cyclophosphamide, Actinomycin-D, Adriamycin and Vinblastine vs. Observation
Activated
04-26-1982
Closed
08-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8200
Evaluation of Vinblastine by Continuous Infusion for Advanced, Recurrent Endometrial Carcinoma
Activated
03-31-1982
Closed
09-27-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8122
Combined Modality Treatment of Extensive Small Cell Lung Cancer
Activated
03-30-1982
Closed
03-22-1985
Closed
Phase
SWOG Clinical Trial Number
SWOG-8161
Evaluation of Bisantrene Hydrochloride in Adult Leukemia
Activated
02-22-1982
Closed
04-20-1984
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8120
Evaluation of Bisantrene Hydrochloride in Gastric Carcinoma
Activated
02-22-1982
Closed
03-16-1984